INCR InterCure Ltd.
5.130USD-3.57%Mkt Cap: 76.97M $P/E: —1d ago
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The c…
Industry Peers
Drug Manufacturers - Specialty & Generic$66.23BUSDP/E 25.7
$58.68BUSD
$45.70BUSDP/E 65.3
GALD
Galderma Group AG$43.27BUSDP/E 56.1
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG$34.93BUSDP/E 60.5
HLN
Haleon plc$32.73BUSDP/E 19.0
$29.57BUSDP/E 11.8
$28.56BUSDP/E 12.2
$23.38BUSDP/E 19.5
$20.09BUSD
$14.43BUSDP/E 112.9
$14.58BUSDP/E 21.0
$12.99BUSDP/E 23.5
$11.17BUSD
$10.22BUSDP/E 27.9
$8.66BUSDP/E 19.3
$6.95BUSDP/E 109.1
$6.89BUSD
$6.84BUSDP/E 40.1
| Headline | Source | Time |
|---|---|---|
Older | ||
 InterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive? InterCure Ltd. (NASDAQ:INCR) finalized a NIS 230 million, or approximately $77 million, settlement with Israeli authorities covering indirect damages from the October 7, 2023 attacks and subsequent war. The more relevant figure for investors is approximately $43 million. The $77 million represents aggregate compensation rather than a new cash payment. InterCure Ltd. (NASDAQ:INCR) previously received […] | ||